Douglas Kramer
Vice President
Clinical Regulatory Affairs & Pharmacovigilance
Athenex
Hong Kong
Biography
Doug has over 20 years of experience in drug development, regulatory affairs and pharmaceutical risk management. His work has included international drug regulatory issues and strategy and development of risk management plans for post marketing drug safety. Doug holds a Doctor of Medicine (MD) degree from Columbia University and a Bachelor of Arts degree in Chemistry from Vassar College.
Research Interest
He has been involved in successful approvals of treatments for addiction (including nicotine replacement and buprenorphine for opioid dependence), opioid analgesics, and IV Temodar for glioblastoma.
